In the event of hyperglycemia with Peg-ASP and steroid therapy, it may be appropriate to reduce the steroid dose and enhance the insulin therapy rather than delay subsequent administrations of Peg-ASP. The gene discussed is INS; the disease is Hyperglycemia.